Publicerad: 2022-03-23 17:02 | Uppdaterad: 2022-03-23 17:09

Aktuella utlysningar, vecka 12, 2022

Grants Office tipsar om aktuella utlysningar

Svenska och nordiska anslag


Grant to host conferences - Scandinavian Society of Clinical Physiology and Nuclear Medicine

Supports scientific symposia within a field of clinical physiology or nuclear medicine, intended to stimulate Nordic science and collaboration, and organised in the society’s member countries. Grants are worth up to SEK 150,000, primarily for invited speakers and other fixed costs, for symposia lasting at least two days.

Closing date: Applications can be submitted at any time

Further information 


EFSD/Novo Nordisk precision diabetes medicine award programme

The programme will accept applications on precision diabetes medicine based on scientific quality, innovation potential and a clear translational focus; bringing basic knowledge to use at the patient level in terms of e.g. disease prognosis, treatment prediction or patient stratification. One award worth DKK 2 million and two awards worth DKK 500,000 each are available each year.

Closing date: 16 May 2022

Further information 


Societal security beyond COVID-19 - NordForsk

Supports research on medium to long-term consequences beyond the COVID-19 pandemic. Grants are worth up to NOK 9 million each.

Closing date: 8 Jun 2022

Further information 


Societal security and antimicrobial resistance – NordForsk

Supports projects that address the effects for individuals and groups, for Nordic societies, and for the Nordic community, of antimicrobial resistance within the thematic framework of the call. Funding is worth up to NOK 3 million for up to two years.

Closing date: 8 Jun 2022

Further information 


Barndiabetesfondens Johnny Ludvigsson-pris till yngre barndiabetesforskare i Sverige 2022

Pristagaren ska vara svensk medborgare och ska ha bedrivit diabetesforskning

  • kliniskt på barn och ungdomar eller/och
  • epidemiologiskt om diabetes hos barn och ungdomar eller/och
  • experimentellt rörande typ 1-diabetes

Användning av biologiskt material från barn och ungdomar och klinisk koppling till barn- och ungdomsdiabetes ska väga tungt i bedömningen.

Pristagaren, som inte får ha fyllt 45 år den 16 oktober det aktuella året, får nomineras av annan diabetesforskare eller så får diabetes-forskaren själv skicka in egen nominering, som skall motiveras genom att på engelska beskriva vetenskaplig insats (max 1000 ord) och bifoga en förteckning över de viktigaste (max 10) vetenskapliga publikationerna.

Priset består av en penningsumma på 50.000 svenska kronor samt ett diplom.

Nomineringar skall vara Barndiabetesfondens kansli tillhanda senast 15 maj 2022.

Vid frågor, kontakta Barndiabetesfondens kansli på e-mail 

Ytterligare information om priset (pdf)


The Swedish Child Diabetes Foundation’s Johnny Ludvigsson-prize for excellent research in childhood and adolescent diabetes

The prize winner should be a Nordic citizen (of Denmark, Finland, Iceland, Norway, or Sweden) and have conducted research in diabetes.

-    clinically in children and adolescents and/or
-    epidemiologically on childhood and adolescent diabetes and/or
-    experimentally regarding type 1 diabetes.

The use of biological samples from children and adolescents and a clinical association will be of great importance in the decision.

The prize winners should be nominated by at least three Nordic researchers in diabetes. The motivation should include a description of the scientific achievement (maximum 1000 words in English) and the most impor-tant (maximum 20) scientific publications. The nomination must be available to the Prize committee by the 15th of May the year of the prize at the latest.

The award consists of a sum of 250.000 SEK and a diploma.

The nomination must be available to the Prize committee by the 15th of May the year of the prize at the latest.

For more information, please contact

Further information

Europeiska anslag

Upcoming Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowships 2022

The MSCA 2022 Postdoctoral Fellowships program will open on April 13th. You can do a postdoc either within Europe with a 2-year fellowship (European Fellowship), or outside Europe (2 years) with a mandatory 1-year return phase to Europe with the 3-year Global Fellowship.

Closing date: 14 September 2022

KI information 

Info about the program

Link to the call

Grants Office organizes an information webinar aimed at KI employees and KI associated researchers, as well as researchers who plan to apply with KI as host organization. Read more about the information webinar and register


Upcoming Marie Skłodowska-Curie Actions (MSCA) Doctoral Networks 2022 (former ITN)

The MSCA 2022 Doctoral Networks program will open 3 May, 2022. Principal Investigators participate or coordiantes a Consortium that applies for a training program for PhD students. The PhD students are to be recruited after the project is awarded. The MSCA Doctoral Networks program includes training networks, Industrial Doctorates and Joint Doctorates.

Closing date: 15 November 2022

KI information

Info about the MSCA DN program

Link to the call


Cancer research award - Dr Josef Steiner Cancer Foundation, CH

The Dr Josef Steiner Cancer Foundation invites applications for its cancer research award. This supports young investigators involved in projects related to the translation of new basic or theoretical insights into clinical applications, within basic or clinical cancer research.

Applicants should typically be 40 years or less, and able to provide the infrastructure needed to carry out the proposed project. Priority is given to applications from scientists based within European institutions.

Funding is worth up to CHF 1 million over four years, and may cover salaries or project co-investigators or staff, equipment and any other project related costs. A personal prize of CHF 50,000 will be awarded to the successful principal investigator.

Pre-proposals due by 15 April 2022; full proposals due by 1 September 2022. This call is repeated every 2 years.

Closing date 15 April 2022

Further information 



Pan-European exchange fellowships - International Brain Research Organization, NL

The International Brain Research Organization invites applications for it’s exchange fellowships. This supports early career neuroscientists from diverse geographic and scientific areas in broadening the scope of their training in neuroscience by conducting goal-directed laboratory visits in established laboratories.

Applicants must be from a Pan-European country and may apply for exchanges only within the Pan-European region. Postdoctoral fellows or junior faculty may apply. Senior PhD students with a good publication record and strong justification for the exchange program are also considered. Applicants should be 45 years or younger. Priority will be given given to applicants from less developed and less well-funded countries in combination with efforts to ensure both gender and regional diversity.

Up to € 8,000 is available to cover travel and local expenses throughout the exchange period. The duration of the exchange should be a minimum of four weeks.

Closing date 18 April 2022

Further information 



Research fellowships - European Society for Paediatric Endocrinology

The European Society for Paediatric Endocrinology, invites nominations for its research fellowships. These support young paediatricians or scientists by financing their research training in a centre of excellence for paediatric endocrinology for a period of up to two years.

Applicants must be based in Europe, be members of the ESPE or have applied for membership at the time of the application and be nominated by their current supervisor or head of department, who must also be a member of ESPE. Current members of the Science Committee and ESPE council are not eligible to apply.

The fellowship is worth up to €125,000 for a duration of up to two years. An additional €15,000 for consumables is available. Two fellowships are available.

Closing date 20 April 2022

Further information


Short-term fellowships - European Society for Immunodeficiencies

The European Society for Immunodeficiencies invites applications for its short-term fellowships. These enable physicians or scientists under specialist training to learn diagnostic and therapeutic procedures or laboratory techniques in the field of primary immunodeficiencies.

Applicants must be current junior members of the society, who are under 35 years of age or between 35 and 40 years of age and in training.

Fellowships are worth €1,500 for a period of one to two months, plus up to €500 for travel support.

Closing date 24 April 2022

Deadline Information Deadlines on: 24 April 2022, 23 October 2022.

Further information 


Medium-term fellowships - European Society for Immunodeficiencies, EUR

The European Society for Immunodeficiencies invites applications for its medium-term fellowships. These support physicians or scientists in specialist training who are interested in pursuing a research project in the field of primary immunodeficiencies.

Applicants must be current ESID junior members who are under 35 years of age, or between 35 and 40 years of age if they are still in training. They must be accepted by a foreign institution for the proposed training goals.

Three fellowships are available, each worth €1,000 per month for between three and six months, plus a travel subsidy of up to €500. Funding may also be used for laboratory or clinical research work.

Closing date 24 April 2022

Deadline Information Deadlines on: 24 April 2022, 23 October 2022.

Further information 


Juniors bridge grants - European Society for Immunodeficiencies, EUR

The European Society for Immunodeficiencies invites applications for its juniors bridge grant. These support trainees working on primary immunodeficiencies in continuing their activity at their institution or another institution during short periods of time until they can find other financial sources.

Applicants must be junior members of the society.

Grants are worth up to €1,500 each per month for up to six months.

Closing date 24 April 2022

Deadline Information Deadlines on: 24 April 2022, 23 October 2022.

Further information 


Young researchers and clinicians grants – hearing science, Fondation pour l’Audition, FR

The Fondation pour l’Audition invites applications for its young researchers and clinicians grants in hearing science. This supports foreign postdoctoral researchers in coming to a French laboratory to perform research in hearing science.

Applicants must not be based in France and must have received their PhD or MD/PhD within the last seven years.

Grants are worth up to €60,000 each per year for two years.

Closing date 25 April 2022

Further information 


Research training workshop call - European Joint Programme on Rare Diseases, EU

The European Joint Programme on Rare Diseases, in partnership with the European Reference Networks, invites applications for its research training workshop call. This supports the organising of a two-day workshop event on rare diseases research with the aim to train researchers and clinicians affiliated to ERN-full members or affiliated partners. Training themes may include innovative research methodologies, diagnostic research methodologies, interdisciplinary treatment approaches, such as gene therapy and transplantation.

The workshops will be attended only by individuals affiliated to ERN institutions. Participants will be selected by the coordinator of the ERN managing institution and the workshop organiser based on pre-defined criteria.

Applicants must be affiliated to a EJP RD beneficiary institution, an ERN full member or to an ERN affiliated partner institution at the time when the application is submitted, as well as during the period of the execution of the workshop.

Up to €25,000 is available for up to seven workshops per year between 2020 and 2023. Funding may cover venue hire, administrative, audio-visual and IT facilities essential for the workshop, travel and accommodation expenses of workshops participants and invited speakers.

Closing date 25 April 2022

Further information


Gender in research fellowship – Netherlands

The Netherlands Organisation for Health Research and Development (ZonMw) invites applications for its gender in research fellowship. This supports graduates and postdoctoral trainees in attending the gender and health course and participate in the gender in research workshop at the Erasmus summer programme, to be held in Rotterdam in August 2022.

Applicants must be registered in a doctoral programme or be within five years of completing their PhD. Applications are invited from all over the globe.

Up to 20 fellowships are available. Funding is worth up to €2,000 for each fellow and includes registration, travel and visa expenses. Accommodation and breakfast are also included.

Closing date 25 April 2022

Further information 


Strategic research centres - Cystic Fibrosis Trust, GB

The Cystic Fibrosis Trust invites expressions of interest for its strategic research centres call. This facilitates creating clusters of researchers carrying out joint research activities in areas of strategic importance to people with cystic fibrosis and their families. The purpose of the programme is to:

•create clusters of internationally competitive researchers;

•exploit opportunities in science where synergy among researchers provides advantages to solve complex questions;

•facilitate the development of new interdisciplinary research partnerships;

•widen awareness of cystic fibrosis research outside the traditional biomedical disciplines and so attract high-quality PIs from new disciplines to apply their skills and knowledge to cystic fibrosis research;

•provide an environment to recruit young researchers and foster their interest in cystic fibrosis.

The PI must be based in the UK, hold an appropriate contract within a UK-based research-focused academic institution and have guaranteed research space for the duration of the grant. Typically, each centre comprises a lead PI together with four or five co-investigators. Co-investigators may be based in any institution worldwide, be in the public or commercial sectors and are not restricted to biomedical sciences. Existing PIs may reapply.

Funding is worth up to £750,000 for three to four years. Stipends of young researchers in training to underpin the team, such as PhD students, research assistants, early-career professionals or early postdoctoral scientists, are supported.

Closing date 25 April 2022

Further information 

Amerikanska anslag


Federal Funding agencies


Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01, R21 Clinical Trial Not Allowed), NIH

The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types of radiation used in radionuclide-based therapeutics (e.g., radiopharmaceutical therapy) on normal tissue, tumor cells Areas of Scientific Priority and Interests

Examples of pre-clinical research supported through this PAR include, but not limited to the following activities:

  • Examine new targets and/or targeting strategies for RPT in the context of cancer cell biology:
  • Innovation in RPT targeting of specific pathways, organelles, or processes;
  • Development of RPT-based synthetic lethality approaches;
  • Pharmacodynamic biomarkers and studies at the interface between biology and microdosimetry to advance theranostic capabilities;
  • Testing the mechanism of action for combinations of RPT and molecular targeted therapies;
  • Understanding polypharmacy mechanisms for RPT-drug combinations;
  • Measurement of RPT biological effects to optimize treatment regimens for recalcitrant resistant or metastatic disease;
  • Examination of RPT biological effects on normal tissues or organs at risk to improve therapeutic index;

Multiple PI leadership structure representing demonstrated expertise in radiopharmaceutical therapy and cancer biology is highly encouraged. and the tumor microenvironment.

Deadline: Standard due dates apply. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-22-139 (R01), PAR-22-140 (R21)

Further info: (R01), (R21)


Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed), NIH

The National Institute on Drug Abuse (NIDA) seeks applications that support generation of single cell RNA-sequencing data sets for at least one brain region relevant to persistent HIV infection and opioid, cocaine, methamphetamine, or cannabinoid use disorder.
This FOA aims to support projects proposing to generate single cell or single nucleus RNA-sequencing data sets for at least one brain region relevant to persistent HIV infection and SUDs. If fully successful, this project will 1. establish gene expression differences in brain cell types, potentially enabling cell type-specific genetic or pharmacological manipulation, 2. reveal the molecular effects of HIV infection/treatment in the CNS, providing potential targets for manipulation of HIV persistence and/or HIV neurobiological sequelae, 3. uncover cell type-specific gene expression changes resulting from chronic opioid, cocaine, methamphetamine and/or cannabinoid exposure providing potential novel therapeutic targets for addiction, and 4. identify potential synergistic effects of chronic addictive substance exposure and HIV infection in the CNS.

Deadline: August 11, 2022. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-DA-23-004

Further info




AACR-Novocure tumour treating fields research grants, American Association for Cancer Research, US

The American Association for Cancer Research, in association with Novocure, invites applications for its tumour treating fields research grants. These support independent investigators in conducting research focused on tumour treating fields, defined as intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells. The award aims to provide a deeper understanding of the mechanisms of action of this novel anti-cancer treatment modality and to accelerate the development of new treatment strategies to advance therapeutic options for cancer. Research may be basic or translational in nature and should promote the transition of in vitro work into in vivo systems.

Applicants must hold a doctoral degree in a relevant field and not currently be a candidate for a further doctoral degree. They should be independent investigators that do not hold an active AACR-Novocure grant. Applicants should be AACR members.

The awards are worth USD 250,000 each over two years.

Deadline: 02/07/2022 1:00 PM (ET).

Further info


Research grants – kidney disease

Polycystic Kidney Disease Foundation, US and other funders (forecast)

he Polycystic Kidney Disease Foundation invites applications for its research grants. These support basic, translational and clinical research that will benefit patients with autosomal dominant polycystic kidney disease and autosomal recessive polycystic kidney disease. Applications may be in the following areas:

  • basic research – to enhance understanding of molecular basis of PKD and its pathobiology;
  • translational research – to accelerate the development of therapeutic strategies for PKD;
  • clinical research – small pilot studies;
  • epidemiology and data analysis research – to conduct secondary data analyses utilising existing database resources, or to develop new statistical methodologies or test hypotheses using existing data.

Applicants must have an M.D., Ph.D. or equivalent degree and hold a faculty appointment at the institution where the research will be conducted at the time of award. Applicants need not be United States citizens. No fellowships will be awarded under this RFA, although salary support for personnel working on the project may be requested. Applicants may only submit one grant proposal per funding cycle.
Awards are worth USD 80,000 each in direct costs per year for a maximum period of two years. Second-year funding is dependent upon availability of funds. An optional third year of support may be available to a young investigators with less than five years from completing post-doctoral or clinical fellowship training.

Deadline: Forecast. Please re-check! August 17, 2022 by 5pm CDT

Further info